Dr. Min Shi is a board-certified hematopathologist and holds the academic rank of Associate Professor at the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota. Dr. Shi is a medical director of the flow cytometry laboratory at Mayo Clinic, a high-volume reference laboratory with samples from all over the world. She has led the design, validation, and implementation of many clinical flow cytometry assays, including an updated version of a T-cell panel using a novel antibody TRBC1 to establish T-cell clonality. She also led the effort to develop decision rules for NK-cell receptor restriction from large cohorts of healthy donors and NK-cell neoplasms. Dr. Shi’s research interest is focused on diagnostic and prognostic markers for hematopoietic malignancies, particularly T-cell and NK-cell lymphoproliferative disorders. She has been awarded several grants in translational medicine and authored more than 90 peer-reviewed articles. Dr. Shi has dedicated herself to education by teaching didactic lectures for residents/fellows/clinical technologists and mentoring them to conduct, present and publish research projects. She has presented multiple talks at regional, national and international conferences.

Louisa Stone works as a laboratory and clinical haematologist at Te Toka Tumai Auckland Hospital. Since completing her haematology training, she has developed a special interest in flow cytometry and in particular, measurable residual disease analysis, under the mentorship of the late Dr Edward Theakston. Louisa works predominantly at LabPlus which provides regional services for flow cytometry, and national MRD analysis for a range of haematologic malignancies, including B-ALL (COG accreditation), AML, CLL and myeloma.